What is it about?
Herpes simplex virus (HSV) is a very common virus affecting a large section of human population worldwide. Recent advances in nanomaterials are showing new promise that human immune mechanisms can be guided to provide better protection and post-infection therapy against the persistent HSV infections, which last for the lifetime of the infected individuals.
Featured Image
Photo by CDC on Unsplash
Read the Original
This page is a summary of: Could Zinc Oxide Tetrapod Nanoparticles Be Used as an Effective Immunotherapy Against HSV-2?, Nanomedicine, August 2016, Taylor & Francis,
DOI: 10.2217/nnm-2016-0249.
You can read the full text:
Contributors
The following have contributed to this page







